Michael Walsh, University of Toronto

Research

Hemodialysis Hyperphosphatemia Clinical Trial Phosphate Binders Cardiovascular Events Dialysis End-Stage Renal Disease Phosphate

Latest papers

Mental health and addiction service utilization among people living with chronic kidney disease
Nephrology Dialysis Transplantation · 2024 · senior author
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
New England Journal of Medicine · 2020 · first author
Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal
American Society of Nephrology. Clinical Journal · 2020 · senior author

All 4 publications

Latest funding

Strategies for the management of Atrial Fibrillation in patiEnts receiving Dialysis 2 (SAFE-D2)
CIHR · 2025 · Co-investigator
$1,874,251
Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)
CIHR · 2024 · Principal investigator
$1,526,176
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1)
CIHR · 2023 · Co-investigator
$566,099

All 7 grants and awards

4 publications.

01

Mental health and addiction service utilization among people living with chronic kidney disease

Bhasin AA, Molnar AO, McArthur E, Nash DM, Busse JW, Cooper R, Heale E, Ip J, Pang J, Blake PG

Nephrology Dialysis Transplantation20248 citationsSenior author

DOI: 10.1093/ndt/gfad240

02

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Fujimoto S, Wald R, Levin A, Gregorini G, Clark WF, Pagnoux C, Specks U, Smyth L, Carette S, Pusey CD

New England Journal of Medicine2020852 citationsFirst author

DOI: 10.1056/nejmoa1803537

03

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal

Evans JM, Glazer A, Lum R, Heale E, MacKinnon M, Blake PG, Walsh M

American Society of Nephrology. Clinical Journal202057 citationsSenior author

DOI: 10.2215/cjn.01840220

04

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides

McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler SM, Cabral DA, Carette S, Cox GP, Dhindsa N

Journal of Rheumatology201670 citations

DOI: 10.3899/jrheum.150376

Strategies for the management of Atrial Fibrillation in patiEnts receiving Dialysis 2 (SAFE-D2)

Co-investigatorCIHR2025Project Grant

Principal investigators: Harel, Ziv; Wald, Ron

Keywords: Apixaban; Atrial Fibrillation; End Stage Renal Disease; Hemodialysis

$1,874,251

Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)

Principal investigatorCIHR2024Project Grant

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Cardiovascular Events; Hemodialysis; Hyperphosphatemia

$1,526,176

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1)

Co-investigatorCIHR2023Project Grant

Principal investigators: Wald, Ron; Cherney, David Z; Clemens, Kristin K; Yau, Kevin

Keywords: Diabetes Mellitus; Dialysis; End-Stage Kidney Disease; Glp-1 Receptor Agonists; Pilot Rct

$566,099

Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)

Principal investigatorCIHR2018Project Grant

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Dialysis; End-Stage Renal Disease; Phosphate; Randomized Control Trial

$1,526,175

Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

Co-investigatorCIHR2018Project Grant

Principal investigators: Harel, Ziv; Wald, Ron

Keywords: Anticoagulation; Apixaban; Atrial Fibrillation; Direct Oral Anticoagulants; Feasibility; Hemodialysis; Warfarin

$314,416

Two phosphAte taRGets in End-stage renal disease Trial (TARGET): Intensive vs liberalized phosphate control in hemodialysis recipients

Principal investigatorCIHR2014Operating Grant

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Clinical Trial; Hemodialysis; Hyperphosphatemia; Phosphate Binders

$168,394

Intensive vs liberalized phosphate control in hemodialysis recipients

Principal investigatorCIHR2012Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Clinical Trial; Hemodialysis; Hyperphosphatemia; Phosphate Binders

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Amit Garg and Ron Wald: 69 shared papers
Michael Walsh and Amit Garg: 53 shared papers
Amber Molnar and Amit Garg: 39 shared papers
Michael Walsh and Ron Wald: 21 shared papers
Michael Walsh and Amber Molnar: 18 shared papers
Nader Khalidi and Gerard Cox: 18 shared papers
Michael Walsh and Nader Khalidi: 17 shared papers
Amit Garg and Ron Wald: 16 shared papers
Amber Molnar and Ron Wald: 13 shared papers
Nader Khalidi and Lillian Barra: 11 shared papers
Ron Wald and Ron Wald: 10 shared papers
Nader Khalidi and Nataliya Milman: 8 shared papers
Amit Garg and Adeera Levin: 7 shared papers
Nader Khalidi and Leilani Famorca: 7 shared papers
Lillian Barra and Nataliya Milman: 7 shared papers
Michael Walsh and Gerard Cox: 5 shared papers
Michael Walsh and Ron Wald: 5 shared papers
Michael Walsh and Adeera Levin: 5 shared papers
Michael Walsh and Nataliya Milman: 5 shared papers
Leilani Famorca and Nataliya Milman: 5 shared papers
Adeera Levin and Adeera Levin: 5 shared papers
Michael Walsh and Michael Walsh: 4 shared papers
Leilani Famorca and Lillian Barra: 4 shared papers
Michael Walsh and Jason Walter Busse: 3 shared papers
Amber Molnar and Jason Walter Busse: 3 shared papers
Amit Garg and Jason Walter Busse: 3 shared papers
Gerard Cox and Leilani Famorca: 3 shared papers
Michael Walsh and Jenna Evans: 2 shared papers
Michael Walsh and Michael Walsh: 2 shared papers
Nader Khalidi and Michael Walsh: 2 shared papers
Adeera Levin and Ron Wald: 2 shared papers
Adeera Levin and Adeera Levin: 2 shared papers
Adeera Levin and Adeera Levin: 2 shared papers
Michael Walsh and Adeera Levin: 1 shared paper
Michael Walsh and Paul Kurdyak: 1 shared paper
Michael Walsh and Adeera Levin: 1 shared paper
Michael Walsh and Michael Walsh: 1 shared paper
Amber Molnar and Michael Walsh: 1 shared paper
Amber Molnar and Paul Kurdyak: 1 shared paper
Amit Garg and Michael Walsh: 1 shared paper
Amit Garg and Paul Kurdyak: 1 shared paper
Amit Garg and Michael Walsh: 1 shared paper
Jason Walter Busse and Michael Walsh: 1 shared paper
Nader Khalidi and Adeera Levin: 1 shared paper
Nader Khalidi and Michael Walsh: 1 shared paper
Nader Khalidi and Michael Walsh: 1 shared paper
Jenna Evans and Michael Walsh: 1 shared paper
Gerard Cox and Michael Walsh: 1 shared paper
Gerard Cox and Michael Walsh: 1 shared paper
Leilani Famorca and Michael Walsh: 1 shared paper
Ron Wald and Michael Walsh: 1 shared paper
Ron Wald and Adeera Levin: 1 shared paper
Adeera Levin and Michael Walsh: 1 shared paper
Ron Wald and Michael Walsh: 1 shared paper
Michael Walsh and Adeera Levin: 1 shared paper
Michael Walsh and Adeera Levin: 1 shared paper
Michael Walsh and Paul Kurdyak: 1 shared paper
Michael Walsh and Adeera Levin: 1 shared paper
Michael Walsh and Lillian Barra: 1 shared paper
Michael Walsh and Michael Walsh: 1 shared paper
Michael Walsh and Michael Walsh: 1 shared paper
Michael Walsh and Nataliya Milman: 1 shared paper

Medicine
Nephrology
Medicine/Nephrology
Health Research Methods, Evidence, and Impact
Anesthesia
Health Policy and Management
Department of Medicine
Other

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Nataliya Milman

Department of Medicine

1 shared papers, latest 2016

Amit Garg

Health Research Methods, Evidence, and Impact

1 shared papers, latest 2024

Jenna Evans

Health Policy and Management

1 shared papers, latest 2020

Ron Wald

Medicine/Nephrology

1 shared papers, latest 2020

Adeera Levin

Medicine/Nephrology

1 shared papers, latest 2020

Amber Molnar

Medicine

1 shared papers, latest 2024

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Hemodialysis Dear Professor Walsh, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Mental health and addiction service utilization among people living with chronic kidney disease" (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Michael Walsh

Research

Latest papers

Latest funding

Mental health and addiction service utilization among people living with chronic kidney disease

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides

Strategies for the management of Atrial Fibrillation in patiEnts receiving Dialysis 2 (SAFE-D2)

Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1)

Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)

Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

Two phosphAte taRGets in End-stage renal disease Trial (TARGET): Intensive vs liberalized phosphate control in hemodialysis recipients

Intensive vs liberalized phosphate control in hemodialysis recipients

Frequent collaborators

Michael Walsh

Nader Khalidi

Adeera Levin

Adeera Levin

Paul Kurdyak

Adeera Levin

Lillian Barra

Michael Walsh

Michael Walsh

Nataliya Milman

Amit Garg

Jason Walter Busse

Jenna Evans

Gerard Cox

Leilani Famorca

Ron Wald

Adeera Levin

Ron Wald

Amber Molnar